Latest Nektar Stories
SAN FRANCISCO, April 23, 2015 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter ended March 31, 2015 on Thursday, April 30, 2015, after
SAN FRANCISCO, April 13, 2015 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its corporate presentation at the 14th Annual Needham
Cash Payment Resulting from First Commercial Sale of MOVANTIK(TM) (naloxegol) Tablets in the US SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced
NEW YORK, March 18, 2015 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether Nektar Therapeutics ("Nektar" or
SAN FRANCISCO, Feb.
SAN FRANCISCO, Jan. 6, 2015 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W.
SAN FRANCISCO, Oct.
EDMONTON, Alberta, Oct.
NEW YORK, Aug. 28, 2014 /PRNewswire/ -- Jeremy B. Edelman, President and Founder of Nektar Naturals Fine Foods announced today that Fields Texas Ltd.
SAN FRANCISCO, July 31, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the second quarter ended June 30, 2014. Cash and investments in marketable